Followers | 10 |
Posts | 232 |
Boards Moderated | 0 |
Alias Born | 06/18/2015 |
![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, February 01, 2016 6:06:35 PM
1) Why does nobody talk about NovaRx's previously failed PIII trial?
I read there were subsets that displayed extremely promising, significant results; but overall it failed to showed statistical improvement.
2) Why would Ivor Royston trash the company in this article but invest years later?
http://www.forbes.com/forbes/2008/1013/116.html
Thanks for any insights, would love to see this one succeed, but also want some more substantive discussion outside of "Cheers, GO VPRO" and "Look, a new website!" on this board.
Good Luck to ALL
-Lord
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM